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ABSTRACT. Obesity is one of the most important nutritional 
disorders, and can be currently considered as an epidemic. Although 
there are few weight reduction drugs available on the market, some new 
drug candidates have been proposed, including Cordia ecalyculata, 
a Brazilian plant with anorectic properties, and Spirulina maxima, 
a cyanobacterium with antioxidant and anti-genotoxic activity. In 
this study, we evaluated the mutagenic potential of C. ecalyculata at 
doses of 150, 300, and 500 mg/kg alone and in association with  S. 
maxima at doses of 75, 150, and 250 mg/kg, respectively, through an 
in vivo micronucleus test, using mice of both sexes, and an in vitro 
micronucleus test and comet assay, using human peripheral blood. For 
all tests, cyclophosphamide was used as a positive control. The results 
showed that treatment of 300 mg/kg C. ecalyculata and the combination 
treatment of 500 mg/kg C. ecalyculata with 250 mg/kg S. maxima 
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resulted in anorectic effects. The mutagenic tests did not reveal any 
clastogenic or genotoxic activity for any treatment, indicating that these 
candidates could be marketed as weight-reduction drugs. Moreover, the 
drugs contain chemo-preventive substances that can protect against 
tumorigenesis, which has been associated with obesity.
Key words: Cordia ecalyculata; Spirulina maxima; Micronucleus; 
Comet assay; Mutagenesis
INTRODUCTION
With increased availability of high-energy foods in combination with a tendency to-
ward more sedentary lifestyles and genetic factors, obesity has emerged as one of the most 
important nutritional disorders, and can be currently considered an epidemic (Francischi et 
al., 2000; Flier and Maratos-Flier, 2013). Obesity is a non-transmissible chronic disease that 
is characterized by excess body fat, and has multifactorial causes (Scarpato et al., 2011; Flier 
and Maratos-Flier, 2013).
According to the World Health Organization (WHO), in 2011 there were 1.6 billion 
adults and 20 million children classified as overweight, and 400 million people were classi-
fied as obese worldwide. The WHO also estimated that by 2015, these numbers will likely 
increase to 2.5 billion overweight and 700 million obese individuals worldwide. In particular, 
a significant increase in the incidence of obesity has been documented in Brazil in conjunction 
with a decrease in malnutrition; in 2003, 40% of the Brazilian population was considered to 
be overweight (Batista-Filho and Rissin, 2003).
This scenario is alarming and constitutes an important public health concern because 
obesity is associated with metabolic, cardiovascular, respiratory, and hepatobiliary diseases as 
well as malignancies, including uterine, cervical, breast, ovarian, endometrial, kidney, gastric, 
esophageal, liver, gallbladder, and pancreatic cancers. Therefore, obesity can generate signifi-
cant costs to the public health system, contributing to 20% of malignancies in women and 14% 
in men (Francischi et al., 2000; Flier and Maratos-Flier, 2013; Boeing, 2013; Lehnert et al., 
2013; Gilbert and Slingerland, 2013; Williams, 2013).
Although pharmacotherapy is indicated for individuals with a body mass index great-
er than 27 kg/m2, there are few weight-reducing drugs available on the market (Francischi et 
al., 2000; Kushner, 2013). The drugs most commonly exploited for appetite suppression have 
two basic pathways of action: 1) central-acting anorectic drugs (sibutramine), which enhance 
the neurotransmission of the monoamines norepinephrine, serotonin, and dopamine; and 2) 
classic adrenergic agents such as benzphetamine, phendimetrazine, diethylpropion, mazindol, 
and phentermine (Kushner, 2013).
However, these substances lead to a diversity of side effects such as increased anxiety, 
drowsiness, gastrointestinal disorders, and cardiac arrhythmias (Francischi et al., 2000; Kush-
ner, 2013), indicating an urgent need for the identification of new weight-reducing agents. 
Indeed, it is estimated that the epidemic control of obesity could prevent approximately 97,000 
deaths resulting from obesity-associated cancers in the United States alone (Gilbert and Sling-
erland, 2013). Among the new candidate drugs that could help in weight reduction are extracts 
of Cordia ecalyculata and the cyanobacteria Spirulina maxima.
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C. ecalyculata Vell. (synonym C. salicifolia Cham.), popularly known as “poranga-
ba”, “buggy tea”, or “coffee bush”, is a shrub with a height of 8-10 m and a diameter of 30-40 
cm belonging to the family Boraginaceae that is distributed throughout the Brazilian territory, 
and is also found in the rainforests of Argentina and Paraguay (Menghini et al., 2008; da Silva 
et al., 2010). Its extract is marketed in Brazil and internationally under the name Pholia magra 
and has diuretic activity, leading to appetite suppression and weight reduction (Menghini et 
al., 2008; da Silva et al., 2010).
Previous studies revealed that C. ecalyculata extract shows inhibitory effects against 
herpes simplex virus type I (Hayashi et al., 1990), and has cardiotonic properties (Matsunaga 
et al., 1997), hypolipidemic effects (Siqueira et al., 2006), and cytotoxicity against certain 
types of tumor cells (Arisawa, 1994). The plant is characterized by high concentrations of caf-
feine, potassium, allantoic acid, and allantoin (Menghini et al., 2008).
S. maxima Setchet Gardner is a non heterocystic, filamentous, planktonic, and pho-
tosynthetic cyanobacterium (Pandey and Tiwari, 2010) belonging to the order Nostocales, 
family Oscillatoriaceae, and is characterized by its 65% protein and 30% essential amino acids 
contents, in addition to containing chelated minerals as iron, potassium, and magnesium, as 
well as vitamins such as biotin, cyanocobalamin, calcium pantothenate, folic acid, inositol, 
thiamine, alpha-tocopherol, pyridoxine and riboflavin, phenolic acids, and beta-carotene, and 
fatty acids such as linoleic and gamalinoleic acid (Dalay, 2002).
S. maxima has anti-inflammatory, analgesic, antioxidant, antiviral, cytostatic, lipolytic, 
hepatoprotective, keratolytic, nutritive, and hypolipidemic activities, and is therefore considered 
to be one of the greatest discoveries of the 21st century in the field of nutrition (Ponce-Canchi-
huamán et al., 2010). Furthermore, studies show that the genus Spirulina has anti-carcinogenic 
and anti-genotoxic properties (Miranda et al., 1998; Mishima et al., 1998; Mittal et al., 1999).
The use of herbal medicine aims to prevent, cure, or minimize disease and its symptoms. 
However, the transformation from a natural product, such as C. ecalyculata and S. maxima, into 
a medicinal product should aim at preserving the chemistry and pharmacological integrity while 
ensuring the maintenance of its biological action and safety for consumption. Thus, toxicologi-
cal genetic tests are essential to guarantee the safety of drug candidates before they can enter the 
international market to ensure that they do not confer a risk of carcinogenesis (Witte et al., 2007).
Among the available genetic toxicological tests, the micronucleus test (MNT) and the 
comet assay are considered to be gold-standard cytogenetic methods (Flores and Yamaguchi, 2008). 
The MNT was developed by Schmid et al. (1975) and was first used in erythrocytes obtained from 
the bone marrow of mice (Ribeiro et al., 2003). This test is widely accepted by international agen-
cies and government institutions as part of a battery test for the assessment of new chemicals or 
drug candidates prior to entering the market (Ribeiro et al., 2003). Therefore, the MNT constitutes 
a major noninvasive cytogenetic technique that can detect chromosomal mutations, which are the 
key mechanism leading to carcinogenic events (Fenech, 2000; Carbonari et al., 2005).
However, the experience gained over several decades of toxicology studies reveals 
that one test is not sufficient to detect all types of mutagenic effects (Witte et al., 2007). Fur-
thermore, a negative result obtained by a test conducted to investigate chromosomal damage 
in rodent hematopoietic cells is not sufficient to conclude that the component is not mutagenic 
to somatic cells. Therefore, based on the correlations between results obtained in rodents and 
humans, the US Food and Drug Administration (FDA) recommended additional testing, both 
in vitro and in vivo (Witte et al., 2007).
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The comet assay, also known as single cell gel electrophoresis, was introduced by 
Östling and Johanson in 1984 and later modified by Singh et al. (1988), and possesses the ad-
vantages of being a simple and versatile technique that requires only a small number of cells 
and can be performed with any eukaryotic cell population (Godschalk et al., 2013). In addi-
tion, the technique has a wide spectrum of DNA damage detection, and can therefore serve as 
an integrator test and a complementary assay to other tests (Godschalk et al., 2013).
Thus, in the present study, we aimed to evaluate the anorectic action and the clasto-
genic and genotoxic potential of C. ecalyculata at three commonly marketed doses (150, 300, 
and 500 mg/kg). We further evaluated these effects when C. ecalyculata was combined with 
S. maxima at respective doses of 75 mg/kg (Ce 150 + Sm 75), 150 mg/kg (Ce 300 + Sm 150), 
and 250 mg/kg (Ce 500 + Sm 250). An in vivo MNT was conducted in polychromatic eryth-
rocytes of mice and two in vitro tests were conducted (an MNT and a comet assay) in human 
binucleated lymphocytes.
MATERIAL AND METHODS
In vivo MNT in polychromatic erythrocytes and anorectic evaluation
We used a total of 80 mice (Mus musculus, albino, Swiss strain), 40 males and 40 
females aged between 7 and 11 weeks, obtained from the central biotery of Universidade 
Estadual Paulista “Júlio de Mesquita Filho” (UNESP). The protocols used were approved by 
the Ethics Committee on Animal Use of the same university (protocol No. 001194/10). The 
choice of mice was based on the fact that oncogenetic and functional studies have shown that 
they do not lose or sequester micronucleated erythrocytes, such as occurs in rats (Ribeiro et 
al., 2003; Griffiths et al., 2005).
The mice were acclimated in the biotery of UNESP - Faculdade de Ciências e Letras 
de Assis - for five days under the following conditions: 12:12-h light/dark cycle, 150 lux light-
ing, temperature of 22° ± 2°C, water and food ad libitum. The mice were divided into eight 
groups of five animals each, separated by sex (Table 1). The analysis of anorectic action was 
conducted by measuring body weight before and after mice received treatments.
Group Treatment In vivo MNT In vitro MNT Comet assay
  Dose (mg/kg) Dose (µL/mL) Dose (µL/mL)
C+ Cyclophosphamide       50          50      50
C- Saline           - Not applied Not applied
Ce 150 C. ecalyculata    150        150    150
Ce 300 C. ecalyculata    300        300    300
Ce 500 C. ecalyculata    500        500    500
Ce 150 + Sm 75 C. ecalyculata + S. maxima    150 + 75 Not tested    150 + 75
Ce 300 + Sm 150 C. ecalyculata + S. maxima    300 + 150 Not tested    300 + 150
Ce 500 + Sm 250 C. ecalyculata + S. maxima    500 + 250 Not tested    500 + 250
Table 1. Different treatments employed, showing doses in mg/kg to in vivo micronucleus test (MNT) and µL/
mL to in vitro MNT and comet assay.
The positive control groups (C+) of both sexes were treated with 50 mg/kg cyclophos-
phamide (Sigma-Aldrich; St. Louis, MO, USA) by intraperitoneal injection, administered in a 
single dose. The negative control groups (C-) of both sexes were treated with 0.3 mL saline by 
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gavage, performed twice a day for seven consecutive days. The experimental groups received 
a final volume of 0.3 mL respective treatment solution (Table 1) through gavage, performed 
twice a day for seven consecutive days. The mice were sacrificed by cervical dislocation 48 
h after the final dose administration. The femurs were removed and the bone marrow was 
extracted by injecting 1 mL fetal bovine serum (Cultilab; Campinas, SP, Brazil). The material 
was homogenized on a Petri dish and centrifuged for 5 min at 36.54 g. The pellet was collected 
and smeared onto 26 x 76-mm slides. The material was fixed in absolute methanol for 5 min 
and subjected to the following staining protocol: 10 min in 100% Giemsa (eosin methylene 
blue), washed in distilled water, placed in a solution of 1:5 Giemsa:phosphate buffer, pH 6.0, 
for 8 min, and washed in xylene. The slides were mounted by gluing a coverslip with Entel-
lan. The material was analyzed under a binocular optical microscope at a total magnification 
of 1000X. A total of 2000 polychromatic erythrocytes were analyzed per animal, and the fre-
quency of micronucleated polychromatic erythrocytes (MNPCEs) per animal was calculated.
The statistical analyses were performed using the Biostat software version 5.0. The 
Student t-test and the nonparametric Wilcoxon test were used to verify the effectiveness of the 
drug on weight loss (i.e., change in weight before and after the different treatments), and analy-
sis of variance (ANOVA) was used for comparisons among the treatment groups. The evalua-
tion of the frequency of MNPCEs was performed using the chi-square test, as recommended by 
Ribeiro et al. (2003). All statistical tests were interpreted at a significance level of 5%.
In vitro MNT in binucleated lymphocytes
Five milliliters peripheral blood was collected from 10 volunteers (5 men and 5 
women), using a heparinized vacutainer system. The subjects were aged 18-25 years and did 
not use drugs or any kind of chemical substance, including alcohol and tobacco. The material 
collected was used in the in vitro MNT and comet assay. The protocols were approved by the 
Ethics Committee in Research of UNESP - Faculdade de Ciências e Letras de Assis (process 
No. 1679/2010).
The material was immediately processed in order to avoid possible damage to the 
DNA. For each individual, five cultures were mounted and distributed into five treatment 
groups, as shown in Table 1. The combination of C. ecalyculata and S. maxima at three dif-
ferent doses was performed as a complementary test to evaluate the clastogenic action of the 
extract of C. ecalyculata since previous studies demonstrated the anti-clastogenic action of S. 
maxima (Miranda et al., 1998; Mishima et al., 1998; Mittal et al., 1999). Thus, the combination 
was not tested in the in vitro MNT but rather through the comet assay, which has high DNA 
damage detection sensitivity.
The cultures were performed by addition of 0.2 mL peripheral blood in a culture flask 
containing 5 mL RPMI 1640 medium, 15% fetal bovine serum, 0.1 mL L-glutamine, and 0.1 
mL phytohemagglutinin. The material was incubated at 37°C for 8 h, and then added to 0.1 
mL C. ecalyculata solutions, respectively (Table 1). After 44 h, 0.2 mL cytochalasin B was 
added to block cytokinesis. After 72 h, the culture was stopped with the addition of 0.5 mL 
methanol:acetic acid fixative (3:1) for 5 min at room temperature. The material was centri-
fuged at 10.39 g and the supernatant was discarded. The pellet was homogenized with 5 mL 
fixative and centrifuged at 10.39 g. The pellet was aspirated and transferred to slides, which 
were stained with a 1:3 Giemsa:phosphate buffer solution, pH 6.8, for 8 min.
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After staining, coverslips were placed on slides with Entellan® and the material was 
analyzed in a blind test under a binocular optical microscope to observe the frequency of 
micronucleated binucleated lymphocytes in a total of 1000 analyzed cells. Statistical analysis 
was performed using the Kruskal-Wallis test followed by a post-hoc Dunn test, both at a sig-
nificance level of 5%.
Comet assay
Slides for the comet assay were prepared as follows: slides of 26 x 76 mm were em-
bedded in a solution of normal melting point agarose (NMA; Invitrogen; Carlsbad, CA, USA) 
diluted in phosphate-buffered solution (PBS) to 1.5% at 60°C, and one side of each slide was 
wiped clean with a paper towel. The slides were dried in a horizontal position overnight.
The blood samples were collected and fractionated into aliquots of 200 μL each in 0.2-
mL polypropylene tubes containing 200 μL solution composed of RPMI 1640 medium with 
different concentrations of the drugs tested (Table 1). One blood aliquot from each donor, not 
treated with any compound was used as a negative control, and one aliquot treated with 50 μL/
mL cyclophosphamide was used as a positive control. Aliquots were incubated at 37°C for 1 
h under constant agitation.
After incubation, the aliquots were centrifuged for 1 min at 504 g, and the supernatant 
was discarded. Ten microliters obtained pellet was added to 75 µL low melting point agarose, 
and a final volume of 85 µL was immediately transferred to NMA pre-coated slides. The slides 
were covered with coverslips and maintained at 4°C for 20 min. The coverslips were gently 
removed and the slides were placed in a coplin jar containing lysis solution [2.5 mM NaCl, 
100 mM ethylenediaminetetraacetic acid (EDTA), 10 mM Tris-HCl, 1.1% Triton X-100, and 
11.2% dimethyl sulfoxide] at 4°C for 1 h. Subsequently, all procedures were conducted under 
dark conditions to prevent the induction of DNA damage.
After lysis, the slides were washed with PBS and transferred to an electrophoresis tank 
containing electrophoresis buffer (300 mM NaOH and 1 mM EDTA, pH >13) at 4°C for 40 min 
to induce unwinding of double-stranded DNA. Next, the electrophoretic run was performed with 
a current of 25 V (0.86 V/cm), 300 mA for 20 min to promote the migration of free DNA frag-
ments toward the anode. The slides were transferred to a coplin jar containing neutralizing buffer 
(400 mM Tris-HCl, pH 7.5) for 5 min. The material was fixed in absolute ethanol for 5 min.
The slides were stained with 75 μL 20 μg/mL ethidium bromide solution, and ana-
lyzed under an epifluorescence microscope (Carl Zeiss Axio Scope A1) equipped with an 
excitation filter of 510-560 nm and barrier of 590 nm, at a total magnification of 400X. One 
hundred nucleoids were analyzed per slide, which were scored on a scale of 0 (without DNA 
damage) to 3 (maximum DNA damage), according to Tug et al. (2011). The scores were ob-
tained by summing the product of the observed number of nucleoids per class by its respective 
class value. Statistical analysis was performed using the Kruskal-Wallis test followed by the 
post-hoc Dunn test, both with a significance level of 5%.
RESULTS
Analysis of the anorectic action
The mice were weighed before and after the treatments and the results are shown in 
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Table 2. The Shapiro-Wilk test revealed that the samples were normally distributed (P > 0.05), 
except for the combination treatment group Ce 500 + Sm 250 of females (P = 0.0183 and P = 
0.0464 before and after treatment, respectively). Based on these data, we performed the Student 
t-test for paired samples that were normally distributed and the nonparametric Wilcoxon test for 
the group of females that did not show normality, both at a significance level of 5%. The results 
indicated significant differences in weight for groups C- and Ce 500 + Sm 250 of males and C+, 
C-, Ce 150, Ce 500, Ce 150 + Sm 75, and Ce 300 + Sm 150 of females (Table 3). In both sexes, 
there was an increase in weight for the negative control groups (C-), as expected. An increase 
in weight was observed in the positive control group (C+) of female mice.
              C+               C-            Ce 150            Ce 300           Ce 500        Ce 150 + Sm 75  Ce 300 + Sm 250   Ce 500 + Sm 250
Male Before After Before After Before After Before After Before After Before After Before After Before After
1 24.2 23.7 28.8 32.1 27.2 25.1 27.8 27.6 29.0 29.5 34.5 35.9 40.2 39.4 39.9 38.9
2 27.7 27.8 32.7 38.6 27.6 28.2 31.0 35.3 33.1 32.9 35.7 34.7 43.8 43.8 43.0 42.9
3 29.0 30.5 35.7 44.6 30.3 33.1 36.2 35.8 36.9 33.3 35.8 37.7 44.3 46.0 47.1 46.0
4 29.8 32.4 37.5 44.8 33.0 38.8 36.2 36.6 40.9 42.7 37.3 37.7 48.0 49.9 47.7 46.4
5 30.1 35.6 38.2 45.1 36.8 39.9 33.1 37.8 44.0 46.0 40.3 40.7 48.9 52.9 55.3 54.7
Means 28.1 30.0 34.5 41.0 30.9 33.0 32.8 34.6 36.7 36.8 36.7 37.3 45.0 46.4 46.6 45.7
SD   2.4   4.5   3.8   5.6   4.0   6.4   3.5   4.0   5.9   7.0   2.2   2.2   3.5   5.2   5.8   5.8
Female Before After Before After Before After Before After Before After Before After Before After Before After
1 21.8 22.7 23.3 26.8 26.7 21.7 23.2 22.7 31.7 29.7 31.8 28.0 36.2 35.2 35.7 35.1
2 24.3 24.6 23.4 27.4 28.6 24.9 26.8 26.8 34.3 30.2 35.5 31.9 37.9 37.8 38.4 36.0
3 27.9 34.6 25.7 30.5 29.0 25.2 29.5 28.7 36.7 33.6 38.6 37.3 40.6 39.3 39.2 39.6
4 31.8 38.3 25.8 30.8 29.3 26.8 31.1 31.4 37.5 35.2 38.8 39.0 41.9 41.2 39.4 40.0
5 36.3 40.5 30.9 31.1 32.1 27.8 34.3 32.9 40.1 39.1 40.3 39.7 42.5 41.6 56.9 57.3
Means 28.4 32.1 25.8 29.3 29.1 25.2 28.9 28.5 36.0 33.5 37.0 35.1 39.8 39.0 41.9 41.6
SD   5.8   8.0   3.0   2.0   1.9   2.3   4.2   4.0   3.1   3.8   3.3   5.0   2.6   2.6   8.5   9.0
Table 2. Body weight before and after the different treatments, of ten mice, being five male and five female, 
followed by the values of mean and stand deviation (SD).
Treatments                                       Male                                           Female
 Statistic values P Statistic values P
C+ -1.7312 0.0792 -2.7500 0.0256
C- -6.9757 0.0011 -4.0307 0.0079
Ce 150 -1.5410 0.0991  9.4007 0.0004
Ce 300 -1.5602 0.0968  1.6054 0.0918
Ce 500 -0.0989 0.4630 -4.7847 0.0044
Ce 150 + Sm 75 -1.2440 0.1407  2.2637 0.0431
Ce 300 + Sm 150 -1.6318 0.0890  4.0000 0.0081
Ce 500 + Sm 250   3.8485 0.0092 t/Wilcoxon = 26.0000 0.3770
Table 3. Statistic results of weight reduction before and after the different treatments for male and female mice, 
followed by the P valor.
The experimental groups showed a weight reduction in males treated with the maximum 
combination dose (Ce 500 + Sm 250) and in females treated with C. ecalyculata alone at doses 
of 150 and 500 mg/kg and in combination with S. maxima at doses of 150 + 75 and 300 + 150 
mg/kg. In order to compare the anorectic action of different treatments, ANOVA was performed 
followed by the post-hoc Tukey test, revealing significant differences in weight between groups 
among the male (F = 4.8723, P = 0.001) and female (F = 14.0667, P = 0.000) mice.
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The anorectic effect was similar among the Ce 300, Ce 500, Ce 150 + Sm 75, Ce 300 
+ Sm 150, and Ce 500 + Sm 250 groups in males, and between the Ce 300 and Ce 500 + Sm 
250 groups in females (Table 4).
Male C+ C- Ce 150 Ce 300 Ce 500 Ce 150 + Sm 75 Ce 300 + Sm 150 Ce 500 + Sm 250
1  -0.5a +3.3a  -2.1a  -0.2ab +0.5ab  +1.4ab   -0.8ab   -1.0ab
2 +0.1a +5.9a +0.6a +4.3ab  -0.2ab   -1.0ab     0.0ab   -0.1ab
3 +1.5a +8.9a +2.8a  -0.4ab   -3.6ab  +1.9ab +1.7ab   -1.1ab
4 +2.6a +7.3a +5.8a +0.4ab +1.8ab  +0.4ab +1.9ab   -1.3ab
5 +5.5a +6.9a +3.7a +4.7ab +2.0ab  +0.4ab +4.0ab   -0.6ab
Female C+ C- Ce 150 Ce 300 Ce 500 Ce 150 + Sm 75 Ce 300 + Sm 150 Ce 500 + Sm 250
1 +0.9a +3.5a  -5.0b  -0.5bc -2.0b  -3.8b -1.0b   -0.6bc
2 +0.3a +4.0a  -3.7b   0.0bc -4.2b  -3.6b -0.1b   -2.4bc
3 +6.7a +4.8a  -3.8b  -0.8bc -3.1b  -1.3b -1.3b +0.4bc
4 +6.5a +5.0a  -2.5b +0.3bc -2.3b +0.2b -0.7b +0.6bc
5 +4.2a +0.2a  -4.3b  -1.4bc -1.0b  -0.6b -0.9b +0.4bc
Numbers followed by at least one equal letter indicate absence of significative statistic differences.
Table 4. Weight difference among the different treatments in both male and female mice, in which negative 
values indicate weight reduction.
In vivo and in vitro MNT
The chi-squared test results showed that the number of micronucleated cells in vivo 
significantly increased in the positive control groups of both sexes, as expected. There was 
no significant difference in the number of micronucleated cells between the negative control 
and experimental groups, thus confirming that the drugs, at the tested doses, did not show any 
aneuploidogenic and/or clastogenic activity in vivo (Table 5).
     Groups of male mice
Treatments 1 2 3 4 5 Total E c2 P
C+   7 6 17   7 3 40   8.0 14.000 0.007
C-   4 3   3   0 1 11   2.2   4.909 0.296
Ce 150   3 1   2   3 3 12   2.4   1.333 0.855
Ce 300   3 3   3   3 1 13   2.6   1.269 0.870
Ce 500   0 1   1   2 0   4   0.8   3.500 0.477
Ce 150 + Sm 75   0 2   0   2 3   7   1.4   5.142 0.272
Ce 300 + Sm 150   1 3   4   0 0   8   1.6   8.250 0.082
Ce 500 + Sm 250   0 3   2   1 1   7   1.4   3.714 0.446
     Groups of female mice
Treatments 1 2 3 4 5 Total E c2 P
C+ 21 6 13 12 8 60 12.0 11.166 0.024
C-   0 0   2   1 0   3   0.6   5.333 0.254
Ce 150   3 3   3   3 3 14   2.8   0.285 0.990
Ce 300   2 4   1   0 2   9   1.8   4.888 0.290
Ce 500   1 0   0   2 2   5   1.0   4.000 0.406
Ce 150 + Sm 75   0 2   2   1 2   7   1.4   2.285 0.683
Ce 300 + Sm 150   4 1   2   2 4 13   2.6   2.769 0.597
Ce 500 + Sm 250   0 0   5   2 2   9   1.8   9.330 0.053
No. of micronucleated cells analysed and expected value (E), Chi-square (c2) and probability (P).
Table 5. Number of micronucleated polychromatic erythrocytes observed per animal of both sexes, followed by total.
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The Kruskal-Wallis test, followed by the post-hoc Dunn test, revealed that the fre-
quency of micronucleated cells in vitro (among 1000 binucleated lymphocytes) differed sig-
nificantly between the positive and negative control groups, although no differences were ob-
served between the experimental groups and the negative control (H = 25.9712, P = 0.0000), 
confirming the in vivo MNT results (Table 6). Together, these results demonstrate that C. 
ecalyculata does not have clastogenic activity.
Sample C+ C- Ce 150 Ce 300 Ce 500
  1    17ª    8b   11b    8b    7b
  2    16ª    7b    1b    1b    1b
  3    11ª    4b    5b    1b    0b
  4    24ª    9b    1b    6b    1b
  5    12ª    3b    2b    0b    3b
  6    12ª    1b    3b    2b    0b
  7    13ª    2b    1b    1b    0b
  8    21ª    4b    5b  17b    2b
  9    18ª    3b    6b  11b    2b
10    17ª    1b    2b    4b    1b
Total 161 42 37 51 17
Number followed by at least one equal letter indicate absence of significative statistic differences.
Table 6. Number of micronucleated cells observed per treatment, followed by the statistic compasison through 
Dunn test.
Comet assay
A total of 100 nucleoids per treatment were analyzed and given a score of 0 to 3, ac-
cording to Tug et al. (2011), and the comet score values are shown in Figure 1. The results of the 
Kruskal-Wallis test, followed by the post-hoc Dunn test, revealed that scores differed signifi-
cantly between the positive and negative control groups, but not among experimental groups, 
and between experimental groups and the negative control (H = 32.7984; P = 0.0000) (Table 
7). These results confirm the data obtained through the in vivo and in vitro MNTs, and further 
validate that the drugs, in the tested doses and in their respective associations, are safe from a 
mutagenic perspective while still demonstrating anorectic properties. Together, the results show 
that these drugs are potential candidates to enter into the global market for obesity treatment.
Figure 1. Histogram showing the total number of comets observed per class in different treatments.
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Figure 2 shows images of micronucleated cells and class 3 comets from the respective 
positive controls and normal cells (i.e., without DNA damage), observed in the experimental 
groups.
Sample C+ C- Ce 150 Ce 300 Ce 500 Ce 150 + Sm 75 Ce 300 + Sm 150 Ce 500 + Sm 250
  1   99a   5b 14b 12b 51b 20b 15b 54b
  2   52ª 11b 25b 15b 49b   6b 18b 36b
  3   91ª   4b   4b 23b   5b   5b   6b 29b
  4   99ª   6b 18b 31b 21b   3b   5b   4b
  5   82ª   7b   3b 25b 10b   3b   5b 10b
  6   43ª 25b 97b 60b   8b 33b 30b 18b
  7 137ª   4b 11b   9b   6b   6b   6b 27b
  8 103ª   6b 20b   3b   3b   5b 14b 31b
  9 104ª   4b 21b   6b   7b 37b 20b   6b
10 110ª   3b 25b   5b 20b 15b 12b 32b
Table 7. Comet score observed per treatment and statistic compasison through Dunn test.
Figure 2. Images of normal polychromatic erythrocytes (A) and micronucleated cell (B), normal binucleated 
lymphocytes (C) and micronucleated cell (D) and comets class 0 (E) and 3 (F).
DISCUSSION
The increased prevalence of obesity has led to a reduction in the quality of life for a 
large proportion of the global population, with clear impacts on public health costs; indeed, 
over 20% of the USA healthcare costs is spent on obesity-associated complications and deaths. 
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Therefore, the search for new treatments that could assist in weight reduction while not con-
ferring additional health risks is necessary (Scarpato et al., 2011; Boeing, 2013; Lehnert et al., 
2013; Gilbert and Slingerland, 2013).
In this regard, the evaluation of DNA damage is an essential part of the characteriza-
tion of new drug candidates before entrance into the global market (Frieauff et al., 2013), 
making genetic toxicology assessment an important tool in drug evaluations (Dertinger et al., 
2011). Among the different mutagenic tests available, the MNT and comet assay have been 
widely adopted to assess the aneuploidogenic, clastogenic, and genotoxic action of drug can-
didates owing to their high sensitivity and low costs and execution times when compared to 
classical cytogenetic methods, which require metaphase observations (Dertinger et al., 2011; 
Frieauff et al., 2013).
The number of cells analyzed varies according to the technique employed. According 
to Ribeiro et al. (2003) and Frieauff et al. (2013), for the MNT in polychromatic erythrocytes, 
analysis of 2000 cells is recommended, whereas for the MNT in binucleated lymphocytes, 
1000 cells are recommended for analysis. In the comet assay, only 100 cells need to be ana-
lyzed because of the high sensitivity of this assay in detecting free DNA fragments (Araldi et 
al., 2013). These values for cells analyzed are based on statistical considerations.
Micronuclei are chromosomal fragments or whole chromosomes that are lost during 
cell division, which can be detected as extra-chromosomal particles (Frieauff et al., 2013), 
indicating chromosome breakage (clastogenicity), which can lead to genomic instability, an 
indicator of oncogenic processes (Fenech, 2000; Araldi et al., 2013).
The evaluation of the anorectic ability of the extract of C. ecalyculata and its associa-
tion with S. maxima showed a weight reduction in the male mice for the combination group 
Ce 500 + Sm 250 and in females for the treatment groups Ce 150, Ce 500, Ce 150 + Sm 75, 
and Ce 300 + Sm 150. However, the ANOVA results revealed a statistically significant ano-
rectic effect only for the female groups of Ce 300 and Ce 500 + Sm 250, as shown in Table 4, 
indicating that treatment with C. ecalyculata alone at a dose of 300 mg/kg and in combination 
with S. maxima at the respective doses of 500 and 250 mg/kg can both contribute to higher 
weight reduction.
These results differ from those observed by da Silva et al. (2010), who did not observe 
an anorectic effect of C. ecalyculata at doses of 500, 1000, and 2000 mg/kg. The difference 
in the anorectic effect observed between the sexes is likely related to differences in the hor-
monal environment, which leads to alteration of gene expression and physiological responses 
to drugs (Guidalini and Tufik, 2007), thereby justifying the need for in vivo testing separately 
between the sexes.
The results of anorectic action in females are particularly relevant as obesity appears to 
be more prevalent in women (Flier and Maratos-Flier, 2013). Although obesity presents a non-
Mendelian pattern of inheritance and there are at least 10 loci associated with obesity, only 3% 
of cases are due to a genetic component, indicating that consumption of high-energy foods and 
sedentary habits are the main risk factors for obesity. Therefore, the search for drugs with dif-
ferent targets has been actively undertaken for the treatment of appetite suppression (Kushner, 
2013). The association of C. ecalyculata extract and S. maximum is an excellent candidate in 
this regard, because these drugs have two action pathways: 1) anorectic central action, facilitat-
ing binding to adenosine receptors, thereby promoting an extension of adrenaline (C. ecalycu-
lata); and 2) peripheral action due the high protein concentrationfound in S. maxima.
5218
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 13 (3): 5207-5220 (2014)
R.P. Araldi et al.
The evaluation of the mutagenic potential of the treatments through the MNT, 
both in vivo and in vitro, and the comet assay revealed that they are safe, as they do not 
show clastogenicity. The tests were conducted in both mouse and human cells, as rec-
ommended by the FDA, thus providing confidence in our results. Similar results were 
observed by da Silva et al. (2010) at doses of 500, 1000, and 2000 mg/kg, who did not 
observe any genotoxic effects in cells from the peripheral blood of mice, as determined 
through a comet assay.
Although there are reports showing cytotoxic effects of other Cordia species due to 
the presence of pyrrolizidine alkaloids, C. ecalyculata does not have cytotoxic activity as 
it lacks this alkaloid (Rapisarda et al., 1993). Moreover, Caparroz-Assef et al. (2005) and 
da Silva et al. (2010) showed that C. ecalyculata does not cause toxicity under chronic use.
Gas chromatography, mass spectrometry, and magnetic resonance imaging analy-
ses have shown that C. ecalyculata is distinguished by the presence of palmitic, myristic, 
stearic, oleic, linoleic acid, and high concentrations of spathulenol, a substance that inhib-
its the growth of Helicobacter pylori strain DSMZ 4867 found in human gastric samples 
(Menghini et al., 2008). Furthermore, C. ecalyculata is rich in tannins and anthocyanins, 
which have antioxidant properties, can modulate the expression of adipokines and prevent 
fat accumulation and insulin resistance type II, a problem frequently observed in obesity 
(Volp et al., 2008).
S. maximum is distinguished by the presence of alpha-tocopherol, which inhibits 
nuclear transcription factor kappa B (NF-kB). When activated by cytokines such as tumor 
necrosis factor-α and interleukin (IL)-6 and IL-8, NF-kB binds to the regulatory sequence 
of genes related to the immune processes, apoptosis, cell plasticity, and development, and is 
therefore related to tumorigenesis (Gilbert and Slingerland, 2013).
Cytokines secreted by preadipocytes attract monocytes and induce high concentra-
tions of leptin, which is responsible for the conversion of monocytes to macrophages that 
contribute to the further production of cytokines and angiogenic factors, thereby creating 
a toxic microenvironment in the adipose tissue of obese individuals that is favorable for 
tumorigenesis (Gilbert and Slingerland, 2013). Given this scenario, the combined treatment 
of C. ecalyculata and S. maxima at a dose of 500 and 250 mg/kg, respectively, is recom-
mended, as this treatment could achieve an anorectic effect while exerting antitumorigenic 
activity due to the presence of tannins and alpha-tocopherol.
In summary, the combined treatment of C. ecalyculata and S. maxima at a dose of 
500 + 250 mg/kg proved to be a promising candidate for weight reduction therapy, and did 
not exhibit mutagenic action in either mouse or human cells while simultaneously confer-
ring anti-carcinogenic action. This effect, coupled with the absence of adverse effects com-
monly observed in other similar treatments with drugs such as sibutramine, shows great 
potential of these new candidates in reducing the incidence of obesity in combination with 
lifestyle changes such as nutritional education and practical exercises.
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